Literature DB >> 26637459

Acute Viral Escape Selectively Impairs Nef-Mediated Major Histocompatibility Complex Class I Downmodulation and Increases Susceptibility to Antiviral T Cells.

Andrea M Weiler1, Arpita Das2, Oluwasayo Akinyosoye2, Sherry Cui3, Shelby L O'Connor4, Elizabeth A Scheef2, Jason S Reed5, Antonito T Panganiban6, Jonah B Sacha7, Eva G Rakasz1, Thomas C Friedrich8, Nicholas J Maness9.   

Abstract

Nef-specific CD8(+) T lymphocytes (CD8TL) are associated with control of simian immunodeficiency virus (SIV) despite extensive nef variation between and within animals. Deep viral sequencing of the immunodominant Mamu-B*017:01-restricted Nef165-173IW9 epitope revealed highly restricted evolution. A common acute escape variant, T170I, unexpectedly and uniquely degraded Nef's major histocompatibility complex class I (MHC-I) downregulatory capacity, rendering the virus more vulnerable to CD8TL targeting other epitopes. These data aid in a mechanistic understanding of Nef functions and suggest means of immunity-mediated control of lentivirus replication.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26637459      PMCID: PMC4733980          DOI: 10.1128/JVI.01975-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Down-modulation of CD8αβ is a fundamental activity of primate lentiviral Nef proteins.

Authors:  Anke Heigele; Michael Schindler; Clement W Gnanadurai; Jolie A Leonard; Kathleen L Collins; Frank Kirchhoff
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

2.  Escape from CD8(+) T cell responses in Mamu-B*00801(+) macaques differentiates progressors from elite controllers.

Authors:  Philip A Mudd; Adam J Ericsen; Benjamin J Burwitz; Nancy A Wilson; David H O'Connor; Austin L Hughes; David I Watkins
Journal:  J Immunol       Date:  2012-03-02       Impact factor: 5.422

3.  Efficient Nef-mediated downmodulation of TCR-CD3 and CD28 is associated with high CD4+ T cell counts in viremic HIV-2 infection.

Authors:  Mohammad Khalid; Hangxing Yu; Daniel Sauter; Shariq M Usmani; Jan Schmokel; Jerome Feldman; Rob A Gruters; Marchina E van der Ende; Matthias Geyer; Sarah Rowland-Jones; Albert D Osterhaus; Frank Kirchhoff
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

4.  Specific CD8+ T cell responses correlate with control of simian immunodeficiency virus replication in Mauritian cynomolgus macaques.

Authors:  Melisa L Budde; Justin M Greene; Emily N Chin; Adam J Ericsen; Matthew Scarlotta; Brian T Cain; Ngoc H Pham; Ericka A Becker; Max Harris; Jason T Weinfurter; Shelby L O'Connor; Michael Piatak; Jeffrey D Lifson; Emma Gostick; David A Price; Thomas C Friedrich; David H O'Connor
Journal:  J Virol       Date:  2012-05-09       Impact factor: 5.103

5.  Tetherin/BST-2 antagonism by Nef depends on a direct physical interaction between Nef and tetherin, and on clathrin-mediated endocytosis.

Authors:  Ruth Serra-Moreno; Kerstin Zimmermann; Lawrence J Stern; David T Evans
Journal:  PLoS Pathog       Date:  2013-07-11       Impact factor: 6.823

6.  Structural basis of evasion of cellular adaptive immunity by HIV-1 Nef.

Authors:  Xiaofei Jia; Rajendra Singh; Stefanie Homann; Haitao Yang; John Guatelli; Yong Xiong
Journal:  Nat Struct Mol Biol       Date:  2012-06-17       Impact factor: 15.369

7.  HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail.

Authors:  Jeremiah F Roeth; Maya Williams; Matthew R Kasper; Tracey M Filzen; Kathleen L Collins
Journal:  J Cell Biol       Date:  2004-11-29       Impact factor: 10.539

8.  Nef-specific CD8+ T cell responses contribute to HIV-1 immune control.

Authors:  Emily Adland; Jonathan M Carlson; Paolo Paioni; Henrik Kløverpris; Roger Shapiro; Anthony Ogwu; Lynn Riddell; Graz Luzzi; Fabian Chen; Thambiah Balachandran; David Heckerman; Anette Stryhn; Anne Edwards; Thumbi Ndung'u; Bruce D Walker; Søren Buus; Philip Goulder; Philippa C Matthews
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

9.  Selection on haemagglutinin imposes a bottleneck during mammalian transmission of reassortant H5N1 influenza viruses.

Authors:  Peter R Wilker; Jorge M Dinis; Gabriel Starrett; Masaki Imai; Masato Hatta; Chase W Nelson; David H O'Connor; Austin L Hughes; Gabriele Neumann; Yoshihiro Kawaoka; Thomas C Friedrich
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Discovery and full genome characterization of a new SIV lineage infecting red-tailed guenons (Cercopithecus ascanius schmidti) in Kibale National Park, Uganda.

Authors:  Michael Lauck; William M Switzer; Samuel D Sibley; David Hyeroba; Alex Tumukunde; Geoffrey Weny; Anupama Shankar; Justin M Greene; Adam J Ericsen; HaoQiang Zheng; Nelson Ting; Colin A Chapman; Thomas C Friedrich; Tony L Goldberg; David H O'Connor
Journal:  Retrovirology       Date:  2014-07-04       Impact factor: 4.602

View more
  3 in total

1.  Maintenance of AP-2-Dependent Functional Activities of Nef Restricts Pathways of Immune Escape from CD8 T Lymphocyte Responses.

Authors:  Blake Schouest; Andrea M Weiler; Sanath Kumar Janaka; Tereance A Myers; Arpita Das; Sarah C Wilder; Jessica Furlott; Melody Baddoo; Erik K Flemington; Eva G Rakasz; David T Evans; Thomas C Friedrich; Nicholas J Maness
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

Review 2.  Optimizing intracellular signaling domains for CAR NK cells in HIV immunotherapy: a comprehensive review.

Authors:  Giorgio Zenere; Omalla Allan Olwenyi; Siddappa N Byrareddy; Stephen E Braun
Journal:  Drug Discov Today       Date:  2019-02-13       Impact factor: 7.851

3.  Nef Secretion into Extracellular Vesicles or Exosomes Is Conserved across Human and Simian Immunodeficiency Viruses.

Authors:  Ryan P McNamara; Lindsey M Costantini; T Alix Myers; Blake Schouest; Nicholas J Maness; Jack D Griffith; Blossom A Damania; Andrew G MacLean; Dirk P Dittmer
Journal:  mBio       Date:  2018-02-06       Impact factor: 7.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.